FOLDNEUTRAL

Return on Equity (ROE)

-11.6%

Higher than 26% of Healthcare sector peers

Updated 94h ago

Sector Performance

26th percentile

FOLD

-11.6%

Sector Median

11.0%

Sector Avg

31.7%

📊

Deep Analysis

Amicus Therapeutics’ Return on Equity (ROE) of -11.6% means the company is currently generating a loss relative to the money shareholders have invested—a negative ROE signals unprofitability.

This performance sits well below its Healthcare sector peers, which have a median ROE of 11.0%, placing FOLD in the 26th percentile among them. The year-over-year change is not available, but the quarter-over-quarter change of -17.2% shows the ROE deepened from -9.9% to -11.6%, a worsening trend. The combination of a deeply negative ROE level and a deteriorating quarter-over-quarter pattern points to elevated investment risk, with no near-term sign of a turnaround in profitability. This negative metric does not support a bullish outlook; however, it aligns with the overall NEUTRAL verdict because it represents a clear weakness that other factors in the analysis may offset, keeping the stock rating balanced.

Frequently Asked Questions

What does the Return on Equity (ROE) tell investors about FOLD?

ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.

How is the Return on Equity (ROE) calculated?

Return on Equity (ROE) is calculated as: Net Income / Shareholders' Equity.

How does FOLD's Return on Equity (ROE) compare to its sector?

FOLD's Return on Equity (ROE) of -11.6% compares to a Healthcare sector median of 11.0%, placing it in the 26th percentile.

Who are FOLD's closest peers by Return on Equity (ROE)?

The closest Healthcare peers by Return on Equity (ROE) include: BIIB (7.7%), BDX (6.6%), ZBH (6.1%), TECH (5.3%), RVTY (3.2%).

The Formula

Net Income / Shareholders' Equity

Why It Matters

ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.